Back
Reshape Lifesciences Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
28
RSLS
Reshape Lifesciences
Last Price:
5.38
Seasonality Move:
38.21%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RSLS is experiencing slight buying pressure.
Reshape Lifesciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.77 | Sell |
| 20-day SMA: | 5.73 | Sell |
| 50-day SMA: | 6.61 | Sell |
| 200-day SMA: | 9.76 | Sell |
| 8-day EMA: | 5.7 | Sell |
| 20-day EMA: | 5.79 | Sell |
| 50-day EMA: | 6.71 | Sell |
| 200-day EMA: | 34.94 | Sell |
Reshape Lifesciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 46.23 | Sell |
| Chaikin Money Flow: | 517410 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.22 - 5.98) | Buy |
| Bollinger Bands (100): | (6.23 - 11.61) | Sell |
Reshape Lifesciences Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reshape Lifesciences Stock
Is Reshape Lifesciences Stock a Buy?
- Reshape Lifesciences share price is 5.66 while RSLS 8-day simple moving average is 5.77, which is a Sell signal.
- The stock price of RSLS is 5.66 while Reshape Lifesciences 20-day SMA is 5.73, which makes it a Sell.
- Reshape Lifesciences 50-day simple moving average is 6.61 while RSLS share price is 5.66, making it a Sell technically.
- RSLS stock price is 5.66 and Reshape Lifesciences 200-day simple moving average is 9.76, creating a Sell signal.
RSLS Technical Analysis vs Fundamental Analysis
Sell
28
Reshape Lifesciences (RSLS)
is a Sell
Is Reshape Lifesciences a Buy or a Sell?
-
Reshape Lifesciences stock is rated a Sell
The current Reshape Lifesciences [RSLS] share price is $5.66. The Score for RSLS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Reshape Lifesciences Stock Info
Market Cap:
2.87M
Price in USD:
5.66
Share Volume:
1.32M
Reshape Lifesciences 52-Week Range
52-Week High:
34.22
52-Week Low:
4.60
Sell
28
Reshape Lifesciences (RSLS)
is a Sell
Reshape Lifesciences Share Price Forecast
-
What is the Reshape Lifesciences stock price today?
The Reshape Lifesciences stock price is 5.66 USD today. -
Will RSLS stock go up or go down?
Reshape Lifesciences> share price is forecast to RISE/FALL based on technical indicators -
Is Reshape Lifesciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reshape Lifesciences is overvalued.
Is Reshape Lifesciences Stock a Buy?
- Reshape Lifesciences share price is 5.66 while RSLS 8-day exponential moving average is 5.70, which is a Sell signal.
- The stock price of RSLS is 5.66 while Reshape Lifesciences 20-day EMA is 5.79, which makes it a Sell.
- Reshape Lifesciences 50-day exponential moving average is 6.71 while RSLS share price is 5.66, making it a Sell technically.
- RSLS stock price is 5.66 and Reshape Lifesciences 200-day simple moving average is 34.94, creating a Sell signal.
Fundamental Analysis of Reshape Lifesciences
Is Reshape Lifesciences a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.09 per share.
Technical Analysis of Reshape Lifesciences
Should I short Reshape Lifesciences stock?
- RSLS Moving Average Covergence Divergence (MACD) indicator is -0.2, suggesting Reshape Lifesciences is a Sell
- Reshape Lifesciences Relative Strength Index (RSI) is 46.23, which suggest Reshape Lifesciences is oversold
- The Bollinger Bands (25) for Reshape Lifesciences is (5.22 - 5.98), which suggest Reshape Lifesciences is a Sell
- The Bollinger Bands (100) for Reshape Lifesciences is (6.23 - 11.61), which suggest Reshape Lifesciences is a Sell
* Reshape Lifesciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.